<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1674">
 <bold>Results:</bold> 548/2794 screened articles were included: 466 (85.0 %) original research, predominantly retrospective 175 (37.6 %) and prospective 119 (25.5 %) observational studies, a smaller proportion of randomised controlled trials (RCTs) of 85 (18.2 %) and non-randomised controlled trials 24 (5.2 %) (Fig. 
 <xref rid="Fig24" ref-type="fig">24</xref>). Study sizes ranged 5 - 22,258 (median 62). Most frequently evaluated interventions: blood products (17.3 %), CPB circuit modification (13.6 %), antifibrinolytics (13.2 %) (Fig. 
 <xref rid="Fig24" ref-type="fig">24</xref>). Publication numbers increased at a mean rate of 6 per year from 14 (1980-85) to 229 (2010-15). Within this group the raise of increase of RCTs was 0 (1980-85) to 35 (2010-15).
</p>
